These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11602149)

  • 41. Nadolol (Corgard).
    Burns-Stewart SM
    Crit Care Nurse; 1983; 3(1):96. PubMed ID: 6130892
    [No Abstract]   [Full Text] [Related]  

  • 42. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical trials in Japan and the United States.
    Alexander JH
    Am Heart J; 2004 Feb; 147(2):200-1. PubMed ID: 14760313
    [No Abstract]   [Full Text] [Related]  

  • 44. Rapid carvedilol up-titration in hospitalized patients with left ventricular systolic dysfunction--data from the Carvedilol in Hospital: Up-titration Limits after Acute Patients Admission registry.
    Martínez-Sellés M; Datino T; Alhama M; Barrueco N; Castillo I; Fernández-Avilés F
    J Cardiovasc Med (Hagerstown); 2010 May; 11(5):352-8. PubMed ID: 20154635
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative dose titration responses to the introduction of bisoprolol or carvedilol in stable chronic systolic heart failure.
    Hamaad A; Lip GY; Nicholls D; MacFadyen RJ
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):437-44. PubMed ID: 17896170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity and hypertension: a common coexistence.
    Mende CW
    J Clin Hypertens (Greenwich); 2012 Mar; 14(3):137-8. PubMed ID: 22372771
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 48. High Dose β-Blocker Therapy Triggers Additional Reverse Remodeling in Patients With Idiopathic Non-Ischemic Cardiomyopathy.
    Nitta D; Kinugawa K; Imamura T; Kato NP; Komuro I
    Int Heart J; 2016 Dec; 57(6):717-724. PubMed ID: 27818482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee FY; Lee SD
    Am J Gastroenterol; 2004 Oct; 99(10):1953-8. PubMed ID: 15447755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure.
    Lund-Johansen P; Omvik P; Nordrehaug JE; White W
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
    [No Abstract]   [Full Text] [Related]  

  • 52. [Heart rate variability dynamics during treatment of arterial hypertension].
    Riabykina GV; Chazova IE; Mychka VB; Shutova LI; Shishova TV; Liutikova LN; Kozhemiakina ESh; Shchedrina EV; Sobolev AV
    Kardiologiia; 2008; 48(7):18-24. PubMed ID: 18789021
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
    Askari H; Semizel E; Bostan OM; Cil E
    Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Variation in the CYP2D6 genotype is not associated with carvedilol dose changes in patients with heart failure.
    Shihmanter R; Nulman I; Goland S; Caspi A; Bar-Haim A; Harary I; Berkovitch M; Arcavi L
    J Clin Pharm Ther; 2014 Aug; 39(4):432-8. PubMed ID: 24673480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Application of beta-blockers for clinical practice].
    Yoshikawa T
    Nihon Rinsho; 2007 May; 65 Suppl 5():98-101. PubMed ID: 17571372
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of carvedilol upon intra- and interventricular synchrony in patients with chronic heart failure.
    Castro PF; Mc-Nab P; Quintana JC; Bittner A; Greig D; Vergara I; Vukasovic JL; Corbalan R; Copaja M; Díaz-Araya G; Chiong M; Troncoso R; Alcaino H; Lavandero S
    Am J Cardiol; 2005 Jul; 96(2):267-9. PubMed ID: 16018855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
    Lobo-Vielma L; Colmenarez-Mendoza H; Donis JH; Sanchez F; Perez A; Villarroel V; Dávila DF
    Int J Cardiol; 2010 Oct; 144(2):302-3. PubMed ID: 19329199
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V; Dhar S; Mandpe L
    Hindustan Antibiot Bull; 2007 Feb-2008 Nov; 49-50(1-4):21-8. PubMed ID: 19957540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypotensive action of ICI66.082, a new beta-adrenergic blocking agent.
    Hansson L; Henningsen NC; Karlberg B; Aberg H; Jameson S; Malmcrona R; Hersvall C
    Int J Clin Pharmacol; 1974 Oct; 10(3):206-11. PubMed ID: 4154313
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative doses and cost: esmolol versus labetalol during electroconvulsive therapy.
    Drop L; Castelli I; Kaufmann M
    Anesth Analg; 1998 Apr; 86(4):916-7. PubMed ID: 9539629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.